These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 19032044)
21. Waist circumference as a screening tool for the identification of adolescents with the metabolic syndrome phenotype. Bitsori M; Linardakis M; Tabakaki M; Kafatos A Int J Pediatr Obes; 2009; 4(4):325-31. PubMed ID: 19922048 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Miccoli R; Bianchi C; Odoguardi L; Penno G; Caricato F; Giovannitti MG; Pucci L; Del Prato S Nutr Metab Cardiovasc Dis; 2005 Aug; 15(4):250-4. PubMed ID: 16054548 [TBL] [Abstract][Full Text] [Related]
23. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F; Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865 [TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539 [TBL] [Abstract][Full Text] [Related]
25. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults. Appel SJ; Harrell JS; Davenport ML J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162 [TBL] [Abstract][Full Text] [Related]
26. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632 [TBL] [Abstract][Full Text] [Related]
27. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence. Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231 [TBL] [Abstract][Full Text] [Related]
28. Computer-based screening of veterans for metabolic syndrome. Keane J; Meier JL; Noth RH; Swislocki AL Metab Syndr Relat Disord; 2009 Dec; 7(6):557-61. PubMed ID: 19558266 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of metabolic syndrome in urban and suburban Rivers State, Nigeria: International Diabetes Federation and Adult Treatment Panel III definitions. Siminialayi IM; Emem-Chioma PC; Odia OJ Niger Postgrad Med J; 2010 Jun; 17(2):147-53. PubMed ID: 20539331 [TBL] [Abstract][Full Text] [Related]
30. Waist circumference, dual-energy X-ray absortiometrically measured abdominal adiposity, and computed tomographically derived intra-abdominal fat area on detecting metabolic risk factors in obese women. Lee K; Lee S; Kim YJ; Kim YJ Nutrition; 2008; 24(7-8):625-31. PubMed ID: 18485667 [TBL] [Abstract][Full Text] [Related]
31. Effects of individual components, time, and sex on prevalence of metabolic syndrome in adolescents. Daratha KB; Bindler RC Arch Pediatr Adolesc Med; 2009 Apr; 163(4):365-70. PubMed ID: 19349566 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of metabolic syndrome in an Indian urban population. Gupta R; Deedwania PC; Gupta A; Rastogi S; Panwar RB; Kothari K Int J Cardiol; 2004 Nov; 97(2):257-61. PubMed ID: 15458693 [TBL] [Abstract][Full Text] [Related]
33. Differing definition-based prevalence of metabolic syndrome in the women of Oman family study: a function of multiparity. Al-barwani SA; Bayoumi RA; Jaju D; Al-Yahyaee SA; Al-Hadabi S; Lopez-Alvarenga JC; Comuzzie AG; Hassan MO Metab Syndr Relat Disord; 2008 Sep; 6(3):197-202. PubMed ID: 18699722 [TBL] [Abstract][Full Text] [Related]
34. Larger hip circumference independently contributed to reduced metabolic risks in Tehranian adult women. Esmaillzadeh A; Mirmiran P; Moeini SH; Azizi F Int J Cardiol; 2006 Apr; 108(3):338-45. PubMed ID: 15963581 [TBL] [Abstract][Full Text] [Related]
35. Lower waist-circumference cutoff point for the assessment of cardiometabolic risk in Koreans. Kim HK; Kim CH; Park JY; Lee KU Diabetes Res Clin Pract; 2009 Jul; 85(1):35-9. PubMed ID: 19410320 [TBL] [Abstract][Full Text] [Related]
36. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Esteghamati A; Ashraf H; Rashidi A; Meysamie A Diabetes Res Clin Pract; 2008 Oct; 82(1):104-7. PubMed ID: 18706730 [TBL] [Abstract][Full Text] [Related]
37. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study. Sharma AM; Wagner T; Marsalek P J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705 [TBL] [Abstract][Full Text] [Related]
38. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Zeller M; Steg PG; Ravisy J; Laurent Y; Janin-Manificat L; L'Huillier I; Beer JC; Oudot A; Rioufol G; Makki H; Farnier M; Rochette L; Vergès B; Cottin Y; Arch Intern Med; 2005 May; 165(10):1192-8. PubMed ID: 15911735 [TBL] [Abstract][Full Text] [Related]
39. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome. Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260 [TBL] [Abstract][Full Text] [Related]
40. Clustering of metabolic factors among the patients with essential hypertension. Abu Siddique M; Sultan MA; Haque KM; Zaman MM; Ahmed CM; Rahim MA; Salman M Bangladesh Med Res Counc Bull; 2008 Dec; 34(3):71-5. PubMed ID: 19476250 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]